| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| Cost of Revenue | $0 | — | — |
| Gross Profit | $0 | — | -100.0% |
| SG&A Expense | $27K | +17.0% | +163.4% |
| Operating Income | -$27K | -17.0% | -338.1% |
| Income Tax | $0 | — | — |
| Net Income | -$27K | -17.0% | -338.1% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8K | +293.7% | +356.1% |
| Current Assets | $21K | +79.1% | +1009.9% |
| Total Assets | $23K | +63.3% | +375.8% |
| Current Liabilities | $121K | +42.5% | +444.8% |
| Total Liabilities | $121K | +42.5% | +444.8% |
| Stockholders' Equity | -$97K |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$85K | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $91K | — | — |
| -464.3% |